drugset / Trial / NCT01279876
Melatonin in Relapsing-Remitting Multiple Sclerosis Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether melatonin is effective in the treatment of relapsing-remitting multiple sclerosis patients as a supplement to the main disease-modifying drugs.
Timeline
- Start
- 2010-10
- Primary completion
- 2014-01
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Melatonin | Small molecule | 3 mg | Oral |